Patent ID: 8669067
Filing Date: 2014-03-11
Classification: G01N

Abstract:
1. A method of detecting the presence of a gastric cancer in an individual suspected or at risk of having gastric cancer, the method comprising: (a) measuring, with an antibody, the concentration of Complement component C9 protein in a blood, plasma or serum sample obtained from an individual suspected or at risk of having gastric cancer, wherein the Complement component C9 protein comprises the amino acid sequence of SEQ ID NO:3, and wherein the antibody specifically binds to the amino acid sequence of SEQ ID NO:1, (b) comparing the concentration measured in step (a) with a standard value range for the concentration of Complement component C9 protein in blood, plasma or serum of healthy individuals, and (c) determining that the individual has or is at risk of having gastric cancer when the concentration of Complement component C9 in the blood, plasma or serum sample of the individual is increased in comparison to the standard value range for the concentration of Complement component C9 protein in blood, plasma or serum of healthy individuals.